Lior Sher, JD
Founder and Executive Director, Vitamin C Institute for Clinical Integration (VCICI)
Lior Sher, JD, is the Founder and Executive Director of the Vitamin C Institute for Clinical Integration (VCICI), a global nonprofit dedicated to advancing the science, clinical application, and translational education of high-dose Vitamin C Therapy (VCT). A thought leader in redox medicine and integrative clinical strategy, Lior has redefined the role of Vitamin C as a cornerstone intervention in the management of cancer, chronic illness, complex infections, and immune dysregulation.
She is the author of The C Word: Conspiracy, Cover-Up, and Controversy—The Forbidden Cures from Cancer to COVID and Beyond, a scientific exposé uncovering the suppressed clinical data and untapped therapeutic potential of Vitamin C. The book explores what conventional medicine has long overlooked, offering clinicians and patients a bold investigation into one of the most underutilized molecules in modern medicine.
With a multidisciplinary background in biotechnology, healthcare innovation, and law, Lior is a patented biomedical inventor, educator, and internationally respected speaker known for translating molecular science into evidence-based, systems-oriented therapeutics. Through VCICI, she leads the Institute’s Certification Program and the annual C-MPOSIUM, a CME/CE-accredited global conference.
Her educational framework emphasizes redox-targeted strategies for endocrine recalibration, immune modulation, mitochondrial repair, and systemic recovery across a spectrum of specialties—including oncology, regenerative medicine, biological dentistry, and holistic veterinary care.
The Ascorbate Clinical Framework: Vitamin C as a Redox Modulator in Recovery and Regenerative Medicinee
Integrating 2024–25 evidence on ascorbate’s role in mitochondrial bioenergetics, endocrine recalibration, immune regulation, and regenerative therapeutics.
Abstract
Vitamin C—more precisely, ascorbate—has long been understood as a micronutrient, antioxidant, or high-dose pro-oxidant. Contemporary evidence, however, positions ascorbate as a catalytic regulator of redox balance, systemic resilience, and terrain stability. Its influence spans mitochondrial bioenergetics, endocrine recalibration, immune modulation, collagen remodeling, and neuroregeneration, elevating it from adjunctive nutrient to core therapeutic driver.
This session introduces the Ascorbate Clinical Framework, a model progressing from terrain preparation and physiological saturation to pharmacologic intervention. Participants will explore how correcting subclinical depletion and sustaining optimal ascorbate levels buffers oxidative stress during surgery, detoxification, infection, and chronic disease—while also enhancing the efficacy and durability of high-dose intravenous Vitamin C (HDIVC).
Special attention will be given to 2024–25 clinical evidence highlighting ascorbate’s role in surgical recovery, oncology, chronic wound healing, infection control, and regenerative medicine applications such as stem cell and exosome therapies. Formulation differences—particularly buffered sodium ascorbate (SA) versus ascorbic acid (AA)—will also be discussed in terms of tolerability, patient adherence, and clinical outcomes.
By reframing ascorbate as a central catalyst for redox recalibration and systemic recovery, this session equips clinicians with practical, evidence-based strategies to integrate Vitamin C into functional, regenerative, and integrative practice—improving both therapeutic efficacy and patient quality of life.
Learning Objectives
Upon completion of this session, participants will be able to:
- Define the role of ascorbate as a redox-active cofactor essential for mitochondrial function, immune modulation, collagen repair, and hormonal balance.
- Recognize the clinical impact of subclinical ascorbate depletion and sustained oxidative stress in surgical recovery, chronic disease, degenerative conditions, and immune dysfunction.
- Describe how maintaining physiologic ascorbate saturation enhances therapeutic synergy across conventional, integrative, and regenerative modalities—improving treatment efficacy, tissue responsiveness, and systemic recovery.
- Apply evidence-based strategies for sustained oral delivery and pharmacologic IV administration of sodium ascorbate to optimize terrain readiness, extend therapeutic efficacy, and improve patient outcomes.
